Compare DELL & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DELL | ABT |
|---|---|---|
| Founded | 1984 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.7B | 152.9B |
| IPO Year | 2013 | 2006 |
| Metric | DELL | ABT |
|---|---|---|
| Price | $393.04 | $93.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $181.63 | $130.90 |
| AVG Volume (30 Days) | ★ 10.0M | 9.6M |
| Earning Date | 05-28-2026 | 04-16-2026 |
| Dividend Yield | 1.23% | ★ 2.76% |
| EPS Growth | ★ 36.05 | N/A |
| EPS | ★ 5.24 | 0.61 |
| Revenue | ★ $113,538,000,000.00 | $44,328,000,000.00 |
| Revenue This Year | $26.19 | $10.75 |
| Revenue Next Year | $8.60 | $8.10 |
| P/E Ratio | ★ $78.02 | $152.64 |
| Revenue Growth | ★ 18.80 | 5.67 |
| 52 Week Low | $110.22 | $81.97 |
| 52 Week High | $469.47 | $137.49 |
| Indicator | DELL | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 55.53 | 61.79 |
| Support Level | $122.88 | $86.02 |
| Resistance Level | $469.47 | $112.81 |
| Average True Range (ATR) | 28.59 | 2.26 |
| MACD | -6.80 | 0.59 |
| Stochastic Oscillator | 41.32 | 77.89 |
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It focuses on premium and commercial personal computers, as well as enterprise on-premises data center hardware. It holds top-three shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners and also relies heavily on channel partners to fulfill its sales.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.